跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
STERI-NEB IPRATROPIUM NEBULISER SOLUTION 250 MCG/ML - HSA Drug Approval Details
Approvals
/
HSA
/
STERI-NEB IPRATROPIUM NEBULISER SOLUTION 250 MCG/ML
Approved
THERAPEUTIC
STERI-NEB IPRATROPIUM NEBULISER SOLUTION 250 MCG/ML
IVAX PHARMACEUTICALS UK (UNITED KINGDOM)
🇸🇬 Health Sciences Authority
Approval Date
Sep 17, 1998
Approval ID
90583a6649828314
Company
IVAX PHARMACEUTICALS UK (UNITED KINGDOM)
Type
Therapeutic
Approval Details
Approval Id
90583a6649828314
Drug Name
STERI-NEB IPRATROPIUM NEBULISER SOLUTION 250 MCG/ML
Product Name
STERI-NEB IPRATROPIUM NEBULISER SOLUTION 250 MCG/ML
Approval Number
SIN10039P
Approval Date
1998-09-17
Registrant
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence Holder
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
SOLUTION
Route Of Administration
RESPIRATORY (INHALATION)
Atc Code
R03BB01
Atc Item Name
ipratropium bromide
Pharma Manufacturer Name
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Active Ingredients
IPRATROPIUM BROMIDE
250 mcg/ml
IPRATROPIUM BROMIDE
250 mcg/ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Sep 17, 1998
Approval ID
90583a6649828314
Type
Therapeutic
Back to HSA Approvals
